lifestyle.washingtonguardian.com

Author: Biovica International

Theis Kipling to Assume Role as CEO of Biovica on May 1, 2026

April 16, 2026
Theis Kipling New CEO for Biovica

April 7, 2026
Biovica International AB – Q3 Interim Report Nov 2025-Jan2026

March 18, 2026
New AACR Data Expand Evidence for TKa In Immunotherapy-Treated Patients and CDK Inhibitor Dose Optimization

March 18, 2026
Nomination Committee for Biovica International AB for the 2026 Annual General Meeting

March 9, 2026
Biovica Announces Planned CEO Succession; Anders Rylander to Step Down During 2026

March 5, 2026
Newly Published Data Reinforce Robust Prognostic Associations for DiviTum(R) TKa in Metastatic Breast Cancer

February 12, 2026
Strong DiviTum TKa Results Published in JCO Precision Oncology

January 27, 2026
Biovica International AB – Q2 Interim report Aug – Oct 2025

December 20, 2025
Biovica Signs Client Bill Agreement with Leading U.S. NCI-Designated Cancer Center

December 15, 2025